Skip to content

Cerevance

  • Platform
  • Tissue Collection
  • Pipeline
  • Team
    • Leadership
    • Advisors
    • Board
    • Investors
  • News
    • Press Releases
    • Media Coverage
  • Careers
  • Contact

News

Press Releases

November 27, 2017

Cerevance Appoints David H. Margolin, M.D., Ph.D., as Senior Vice President of Clinical and Translational Medicine

October 24, 2017

Trailblazer in Molecular Genetics and Neuroscience, Jeremy Nathans, M.D., Ph.D., to Advise Cerevance

October 17, 2017

Cerevance Licenses Human Brain Tissue Profiling Technology from The Rockefeller University

October 12, 2017

Harvard’s Rudolph Tanzi, Ph.D., a Leader in Alzheimer’s Disease Genetics, Joins Cerevance’s Advisory Board

October 5, 2017

Stanford Neuroscientist, Robert Malenka, M.D., Ph.D., to Advise Cerevance

May 3, 2017

Dementia Discovery Fund to Invest $5M in Cerevance to Seek New Treatments for Dementia

December 2, 2016

Cerevance Launched With New Technology, Drug Portfolio and $36M in Cash to Tackle Brain Diseases

  • 1
  • 2
  • 3

View Media Coverage

Cerevance
  • Platform
  • Tissue Collection
  • Pipeline
  • Team
  • News
  • Careers
  • Contact
Copyright Cerevance 2022